Leukemia & Lymphoma, Volume 54, Issue 11 (2013)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 54, Issue 11 (2013)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Volume 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries on selected articles in this issue

Article Commentary
Peripheral T-cell lymphomas: in “real life” experience are we really improving?
Pier Luigi Zinzani
Pages: 2337-2338
Published online: 20 Mar 2013
CitationforPeripheral T-cell lymphomas: in “real life” experience are we really improving? | Full Text | References | PDF (129.3 KB) | Supplemental
  • 593 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Article Commentary
Bendamustine: a bridge to longer term solutions in heavily treated Hodgkin lymphoma
Alison Moskowitz
Pages: 2339-2340
Published online: 07 Oct 2013
CitationforBendamustine: a bridge to longer term solutions in heavily treated Hodgkin lymphoma | Full Text | References | PDF (127.2 KB) | Supplemental
  • 967 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Time to look for CD30 expression in diffuse large B-cell lymphomas, along the way to immunotherapy
Francisco Vega
Pages: 2341-2342
Published online: 15 May 2013
CitationforTime to look for CD30 expression in diffuse large B-cell lymphomas, along the way to immunotherapy | Full Text | References | PDF (133.4 KB) | Supplemental
  • 843 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
There is life in the old dog yet: thymidine kinase as predictive marker in diffuse large B-cell lymphoma
Clemens-Martin Wendtner
Pages: 2343-2344
Published online: 16 Jul 2013
CitationforThere is life in the old dog yet: thymidine kinase as predictive marker in diffuse large B-cell lymphoma | Full Text | References | PDF (129.5 KB) | Supplemental
  • 540 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
What is Waldenström macroglobulinemia?
Morie A. Gertz
Pages: 2345-2346
Published online: 29 Jul 2013
CitationforWhat is Waldenström macroglobulinemia? | Full Text | References | PDF (130 KB) | Supplemental
  • 921 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Reversing multidrug resistance (MDR1, ABCB1) in acute myeloid leukemia: back to the ABCs
Deborah Rund
Pages: 2347-2348
Published online: 30 Apr 2013
CitationforReversing multidrug resistance (MDR1, ABCB1) in acute myeloid leukemia: back to the ABCs | Full Text | References | PDF (128.5 KB) | Supplemental
  • 522 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Bone marrow fibrosis: a prognostic scar in hematological malignancies
Tamar Tadmor & Aaron Polliack
Pages: 2349-2350
Published online: 07 May 2013
CitationforBone marrow fibrosis: a prognostic scar in hematological malignancies | Full Text | References | PDF (134.7 KB) | Supplemental
  • 681 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Review Article
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
Richard Rosenquist, Diego Cortese, Sujata Bhoi, Larry Mansouri & Rebeqa Gunnarsson
Pages: 2351-2364
Published online: 30 Apr 2013
AbstractforPrognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand? | Full Text | References | PDF (604.6 KB) | Supplemental
  • 5595 Views
  • 48 CrossRef citations
  • 0Altmetric
Free Access

Review Article

Review Article
Targeting oncogenic and epigenetic survival pathways in lymphoma
Lori A. Leslie & Anas Younes
Pages: 2365-2376
Published online: 22 Apr 2013
AbstractforTargeting oncogenic and epigenetic survival pathways in lymphoma | Full Text | References | PDF (569.9 KB) | Supplemental
  • 567 Views
  • 8 CrossRef citations
  • 0Altmetric
Review Article
The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal
Panagiotis Baliakas, George Kanellis, Niki Stavroyianni, Maria Fameli, Achilles Anagnostopoulos, Kostas Stamatopoulos & Theodora Papadaki
Pages: 2377-2384
Published online: 15 May 2013
AbstractforThe role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal | Full Text | References | PDF (786.8 KB) | Supplemental
  • 430 Views
  • 4 CrossRef citations
  • 0Altmetric

Emerging Drug Profile

Article
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
Jan A. Burger & Joseph J. Buggy
Pages: 2385-2391
Published online: 28 Aug 2013
AbstractforBruton tyrosine kinase inhibitor ibrutinib (PCI-32765) | Full Text | References | PDF (353.1 KB) | Supplemental
  • 3785 Views
  • 119 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Peripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution
Florence Broussais-Guillaumot, Diane Coso, Nawel Belmecheri, Vadim Ivanov, Jean-Marc Schiano de Collela, Thérèse Aurran-Schleinitz, Anne-Marie Stoppa, Bruno Chetaille, Luc Xerri, Benjamin Esterni, Didier Blaise & Reda Bouabdallah
Pages: 2392-2398
Published online: 27 Mar 2013
AbstractforPeripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution | Full Text | References | PDF (536.7 KB) | Supplemental
  • 446 Views
  • 9 CrossRef citations
  • 0Altmetric

Research Article

Article
Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients
Hervé Ghesquières, Aspasia Stamatoullas, Olivier Casasnovas, Franck Morschhauser, Emmanuel Gyan, Jean Gabarre, Marion Malphettes, Laurence Clément, Céline Ferlay & Pauline Brice
Pages: 2399-2404
Published online: 13 Mar 2013
AbstractforClinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients | Full Text | References | PDF (258.4 KB) | Supplemental
  • 579 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Frequency and extent of CD30 expression in diffuse large B-cell lymphoma and its relation to clinical and biologic factors: a retrospective study of 167 cases
Germán Campuzano-Zuluaga, Maureen Cioffi-Lavina, Izidore S. Lossos & Jennifer R. Chapman-Fredricks
Pages: 2405-2411
Published online: 04 Apr 2013
AbstractforFrequency and extent of CD30 expression in diffuse large B-cell lymphoma and its relation to clinical and biologic factors: a retrospective study of 167 cases | Full Text | References | PDF (437.2 KB) | Supplemental
  • 719 Views
  • 36 CrossRef citations
  • 0Altmetric
Article
Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone
Kazuhito Suzuki, Yasuhito Terui, Masahiro Yokoyama, Kyoko Ueda, Noriko Nishimura, Yuko Mishima, Sakura Sakajiri, Naoko Tsuyama, Kengo Takeuchi & Kiyohiko Hatake
Pages: 2412-2417
Published online: 14 Mar 2013
AbstractforPrognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone | Full Text | References | PDF (230.6 KB) | Supplemental
  • 152 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma
Luigi Panico, Fioravante Ronconi, Marianna Lepore, Valentina Tenneriello, Nicola Cantore, Antonietta Carmela Dell’Angelo, Umberto Ferbo & Felicetto Ferrara
Pages: 2418-2425
Published online: 11 Apr 2013
AbstractforPrognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma | Full Text | References | PDF (247.4 KB) | Supplemental
  • 326 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma
Matthias Schwenkglenks, Kate Louise Bendall, Alena M. Pfeil, Zsolt Szabo & Ruth Pettengell
Pages: 2426-2432
Published online: 17 Apr 2013
AbstractforExternal validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma | Full Text | References | PDF (251.1 KB) | Supplemental
  • 251 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors
Daan Dierickx, Thomas Tousseyn, Xavier Sagaert, Steffen Fieuws, Iwona Wlodarska, Julie Morscio, Lieselot Brepoels, Dirk Kuypers, Johan Vanhaecke, Frederik Nevens, Geert Verleden, Rita Van Damme-Lombaerts, Marleen Renard, Jacques Pirenne, Christiane De Wolf-Peeters & Gregor Verhoef
Pages: 2433-2440
Published online: 09 Apr 2013
AbstractforSingle-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors | Full Text | References | PDF (388.6 KB) | Supplemental
  • 979 Views
  • 86 CrossRef citations
  • 0Altmetric
Article
Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma
Kazunari Aoki, Takayuki Takahashi, Sumie Tabata, Masayuki Kurata, Akiko Matsushita, Kenichi Nagai & Takayuki Ishikawa
Pages: 2441-2447
Published online: 17 Apr 2013
AbstractforEfficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma | Full Text | References | PDF (226.4 KB) | Supplemental
  • 517 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy
Ellen Koch, Sara K. Story & Larisa J. Geskin
Pages: 2448-2451
Published online: 08 Apr 2013
AbstractforPreemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy | Full Text | References | PDF (242.7 KB) | Supplemental
  • 514 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Cytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapy
Hong-Hu Zhu, Hao Jiang, Bin Jiang, Jin Lu, Qian Jiang, Li Bao, Xiao-Hui Zhang, Ya-Zhen Qin & Xiao-Jun Huang
Pages: 2452-2457
Published online: 02 Apr 2013
AbstractforCytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapy | Full Text | References | PDF (250.1 KB) | Supplemental
  • 343 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy
Esther N. Oliva, Roberto Latagliata, Carmelo Laganà, Massimo Breccia, Sara Galimberti, Fortunato Morabito, Antonella Poloni, Enrico Balleari, Agostino Cortelezzi, Giuseppe Palumbo, Grazia Sanpaolo, Antonio Volpe, Giorgina Specchia, Carlo Finelli, Maria Grazia D’Errigo, Filippo Rodà, Caterina Alati, Giuliana Alimena, Francesco Nobile & Maria A. Aloe Spiriti
Pages: 2458-2465
Published online: 27 Mar 2013
AbstractforLenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy | Full Text | References | PDF (555 KB) | Supplemental
  • 936 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes
Xiaoliu Liu, Guangsen Zhang, Yan Yi, Le Xiao, Minfei Pei, Sufang Liu, Yunya Luo, Haiying Zhong, Yunxiao Xu, Wenli Zheng & Jiankai Shen
Pages: 2466-2473
Published online: 27 Mar 2013
AbstractforDecreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes | Full Text | References | PDF (1.6 MB) | Supplemental
  • 558 Views
  • 43 CrossRef citations
  • 0Altmetric
Article
Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant
Celalettin Eroglu, Cigdem Pala, Leylagül Kaynar, Kadir Yaray, M. Tarkan Aksozen, Mehmet Bankir, Gökmen Zararsız, Okan Orhan, Mete Gündog, Oguz G. Yıldız, Bülent Eser, Mustafa Cetin & Ali Unal
Pages: 2474-2479
Published online: 27 Mar 2013
AbstractforComparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant | Full Text | References | PDF (203 KB) | Supplemental
  • 692 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Autologous transplant in multiple myeloma with an augmented conditioning protocol
Badran Abu Zaid, Ali Abdul-Hai, Itamar Grotto, Lillian Dray, Igor B. Resnick, Panagiotis D. Tsirigotis, Simcha Samuel, Reuven Or & Michael Y. Shapira
Pages: 2480-2484
Published online: 11 Apr 2013
AbstractforAutologous transplant in multiple myeloma with an augmented conditioning protocol | Full Text | References | PDF (194 KB) | Supplemental
  • 207 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors
Marzia Varettoni, Silvia Zibellini, Daniela Capello, Luca Arcaini, Davide Rossi, Cristiana Pascutto, Sara Rattotti, Silvia Mangiacavalli, Lara Pochintesta, Manuel Gotti, Gianluca Gaidano & Mario Cazzola
Pages: 2485-2489
Published online: 17 Apr 2013
AbstractforClues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors | Full Text | References | PDF (229.2 KB) | Supplemental
  • 482 Views
  • 22 CrossRef citations
  • 0Altmetric

Research Article

Article
Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms’ tumor antigen in patients with non-Hodgkin lymphoma
Anna Israyelyan, Corinna La Rosa, Weimin Tsai, Teodora Kaltcheva, Tumul Srivastava, Lia Aquino, Jianqiang Li, Young Kim, Joycelynne Palmer, Leanne Streja, David Senitzer, John A. Zaia, Andreas Rosenwald, Stephen J. Forman, Ryotaro Nakamura & Don J. Diamond
Pages: 2490-2499
Published online: 30 Apr 2013
AbstractforDetection and preliminary characterization of CD8+T lymphocytes specific for Wilms’ tumor antigen in patients with non-Hodgkin lymphoma | Full Text | References | PDF (2 MB) | Supplemental
  • 209 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
GA101 induces NK-cell activation and antibody-dependent cellular cytotoxicity more effectively than rituximab when complement is present
Delila J. Kern, Britnie R. James, Sue Blackwell, Christian Gassner, Christian Klein & George J. Weiner
Pages: 2500-2505
Published online: 16 Apr 2013
AbstractforGA101 induces NK-cell activation and antibody-dependent cellular cytotoxicity more effectively than rituximab when complement is present | Full Text | References | PDF (294 KB) | Supplemental
  • 616 Views
  • 49 CrossRef citations
  • 0Altmetric
Article
Involvement of c-Jun N-terminal kinase in reversal of multidrug resistance of human leukemia cells in hypoxia by 5-bromotetrandrine
Wei Zhang, Bao-an Chen, Jun-fei Jin, You-ji He & Yi-qi Niu
Pages: 2506-2516
Published online: 02 Apr 2013
AbstractforInvolvement of c-Jun N-terminal kinase in reversal of multidrug resistance of human leukemia cells in hypoxia by 5-bromotetrandrine | Full Text | References | PDF (5.3 MB) | Supplemental
  • 163 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells
Chen Chen, Wei Xu & Cheng-mei Wang
Pages: 2517-2522
Published online: 08 Apr 2013
AbstractforCombination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells | Full Text | References | PDF (423.2 KB) | Supplemental
  • 320 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Immunophenotypic profile of nucleated erythroid progenitors during maturation in regenerating bone marrow
Michaela Fajtova, Anna Kovarikova, Peter Svec, Esko Kankuri & Jan Sedlak
Pages: 2523-2530
Published online: 23 Apr 2013
AbstractforImmunophenotypic profile of nucleated erythroid progenitors during maturation in regenerating bone marrow | Full Text | References | PDF (4 MB) | Supplemental
  • 2072 Views
  • 31 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant
Sally Arai, Michelle Fanale, Sven deVos, Andreas Engert, Tim Illidge, Peter Borchmann, Anas Younes, Franck Morschhauser, Alex McMillan & Sandra J. Horning
Pages: 2531-2533
Published online: 05 Jun 2013
First Page PreviewforDefining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant | Full Text | References | PDF (179.8 KB) | Supplemental
  • 1378 Views
  • 106 CrossRef citations
  • 0Altmetric

Letter

Letter
Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study
Tara L. Chen, Elihu H. Estey, Megan Othus, Kelda M. Gardner, Lauren J. Markle & Roland B. Walter
Pages: 2534-2536
Published online: 27 Mar 2013
First Page PreviewforCyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study | Full Text | References | PDF (143.9 KB) | Supplemental
  • 225 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosis
Aziz Nazha, Zeev Estrov, Jorge Cortes, Carlos E. Bueso-Ramos, Hagop Kantarjian & Srdan Verstovsek
Pages: 2537-2539
Published online: 21 Feb 2013
First Page PreviewforPrognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosis | Full Text | References | PDF (261.9 KB) | Supplemental
  • 202 Views
  • 15 CrossRef citations
  • 0Altmetric
Letter
Spontaneous remission of chemo-immunotherapy related, non-transplant Epstein–Barr virus-associated lymphoproliferative disorder in a patient with chronic lymphocytic leukemia
Preetesh Jain, Ohad Benjamini, Sergej Konoplev, Mohamed Shamel Mohamed, Carlos Guillermo Romo & Zeev Estrov
Pages: 2540-2542
Published online: 08 Mar 2013
First Page PreviewforSpontaneous remission of chemo-immunotherapy related, non-transplant Epstein–Barr virus-associated lymphoproliferative disorder in a patient with chronic lymphocytic leukemia | Full Text | References | PDF (355.9 KB) | Supplemental
  • 103 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Chronic myeloid leukemia survival in older population in the United States
Binay Kumar Shah & Krishna Bilas Ghimire
Pages: 2543-2544
Published online: 08 Mar 2013
CitationforChronic myeloid leukemia survival in older population in the United States | Full Text | References | PDF (131.7 KB) | Supplemental
  • 81 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Graft-versus-lymphoma effect plus vorinostat as successful approach in a case of refractory gastric peripheral T cell lymphoma, not otherwise specified, after reduced intensity conditioning allogeneic hematopoietic cell transplant
Srinivas S. Devarakonda, Jaime L. Shahan, Amol Takalkar, Shubnum I. Chaudhery, Gary Jean, Nebu V. Koshy & Gerhard C. Hildebrandt
Pages: 2545-2547
Published online: 13 Aug 2013
First Page PreviewforGraft-versus-lymphoma effect plus vorinostat as successful approach in a case of refractory gastric peripheral T cell lymphoma, not otherwise specified, after reduced intensity conditioning allogeneic hematopoietic cell transplant | Full Text | References | PDF (358.8 KB) | Supplemental
  • 151 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
New mitogens in cultures for multiple myeloma cytogenetic analysis
Laura López de Frutos, Yolanda Álvarez, Gemma Armengol & María Rosa Caballín
Pages: 2548-2550
Published online: 13 Mar 2013
First Page PreviewforNew mitogens in cultures for multiple myeloma cytogenetic analysis | Full Text | References | PDF (141.2 KB) | Supplemental
  • 238 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Mutation analysis of DICER1 gene in hematologic tumors
Sung Hak Lee, Min Sung Kim, Nam Jin Yoo & Sug Hyung Lee
Pages: 2551-2552
Published online: 19 Mar 2013
CitationforMutation analysis of DICER1 gene in hematologic tumors | Full Text | References | PDF (186.6 KB) | Supplemental
  • 153 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Combination of albumin-bound paclitaxel and pegylated liposomal doxorubicin is effective in treatment of heavily treated relapsed/refractory diffuse large B-cell lymphoma: a case report
Liang Wang & Zhong-Jun Xia
Pages: 2553-2555
Published online: 27 Mar 2013
First Page PreviewforCombination of albumin-bound paclitaxel and pegylated liposomal doxorubicin is effective in treatment of heavily treated relapsed/refractory diffuse large B-cell lymphoma: a case report | Full Text | References | PDF (1.6 MB) | Supplemental
  • 258 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Prognostic value of high serum lactate dehydrogenase in plasma cell dyscrasias: a re-evaluation in the context of cytogenetic aberration data
Gang An, Lihui Shi, Yan Xu, Dehui Zou, Shuhui Deng, Weiwei Sui, Guoqing Zhu, Zhenqing Xie, Mu Hao, Qi Sun, Fenghuang Zhan & Lugui Qiu
Pages: 2556-2559
Published online: 02 Apr 2013
First Page PreviewforPrognostic value of high serum lactate dehydrogenase in plasma cell dyscrasias: a re-evaluation in the context of cytogenetic aberration data | Full Text | References | PDF (265.8 KB) | Supplemental
  • 170 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Frequencies of immature CD34 + CD38 − and CD34 + CD38−CD19 + blasts correlate with minimal residual disease level in pediatric B-cell precursor acute lymphoblastic leukemia
Tatsiana V. Shman, Ludmila V. Movchan & Olga V. Aleinikova
Pages: 2560-2562
Published online: 11 Apr 2013
First Page PreviewforFrequencies of immature CD34 + CD38 − and CD34 + CD38−CD19 + blasts correlate with minimal residual disease level in pediatric B-cell precursor acute lymphoblastic leukemia | Full Text | References | PDF (580.2 KB) | Supplemental
  • 140 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Bortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphoma
Christopher S. Hourigan, Patrick M. Forde, Richard F. Ambinder & Douglas E. Gladstone
Pages: 2563-2564
Published online: 19 Apr 2013
CitationforBortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphoma | Full Text | References | PDF (128.5 KB) | Supplemental
  • 339 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia
Sujayita Roy, Francescopaolo Di Cello, Jeanne Kowalski, Alexandra C. Hristov, Hua-Ling Tsai, Deepa Bhojwani, Julia A. Meyer, William L. Carroll, Amy Belton & Linda M. S. Resar
Pages: 2565-2567
Published online: 30 Apr 2013
First Page PreviewforHMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia | Full Text | References | PDF (323.9 KB) | Supplemental
  • 322 Views
  • 22 CrossRef citations
  • 0Altmetric
Letter
Mixed T/myeloid phenotype acute leukemia with rare variants of IDH1 and CEBPA
Qinling Ma, Yin Tong, Jie Jin & Yinjun Lou
Pages: 2568-2570
Published online: 16 Apr 2013
First Page PreviewforMixed T/myeloid phenotype acute leukemia with rare variants of IDH1 and CEBPA | Full Text | References | PDF (4.1 MB) | Supplemental
  • 234 Views
  • 2 CrossRef citations
  • 0Altmetric

Correspondence

Article
FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein–Barr virus status
Hervé Ghesquières, Ahmet Dogan, Brian K. Link, Matthew J. Maurer, Julie M. Cunningham, Anne J. Novak, Beth R. Larrabee, Susan L. Slager, Cristine Allmer, Thomas M. Habermann, Stephen M. Ansell & James R. Cerhan
Pages: 2571-2573
Published online: 03 Jun 2013
First Page PreviewforFCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein–Barr virus status | Full Text | References | PDF (148.6 KB) | Supplemental
  • 152 Views
  • 7 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Direct and indirect costs for patients with myeloproliferative neoplasms
Jingbo Yu et al.
Article | Published online: 27 Apr 2024
Open Access
Targets and treatments in primary CNS lymphoma
Christina von Roemeling et al.
Review Article | Published online: 24 Apr 2024
Open Access
Challenges in management of older patients with chronic myeloid leukemia
Jessica M. Stempel et al.
Review Article | Published online: 23 Apr 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr et al.
Article | Published online: 23 Apr 2024
Open Access
View all latest articles